On the 7th September 2020, the SDRC hosted our fifth annual conference. The Conference was our biggest event yet. Over 240 people registered to attend, with three plenary speakers, eight early career researchers, 15 poster exhibitors and four exhibition stands. Thank you to everyone who attended and made the event such a success. However, if you were unable to attend the SDRC Conference, we have included a summary below.

Chaired by Professor Craig Ritchie, the SDRC Conference 2020 was titled Unlocking the Mysteries of Data. It focussed on the world of big data and informatics in dementia and brain health research. The speaker presentations will be shared in full on our website shortly.

The first speaker was Professor Timothy Croudace. Professor Croudace discussed health data in research and health science in a digitally connected world. Our second and third speakers, Professor Joanna Wardlaw and Dr Graciela Muniz Terrera were both invited to speak by the SDRC as they had both jointly produced the most publications in 2019, as identified in our SDRC Annual Report. Professor Joanna Wardlaw presented her research in vascular disease and dementia. Dr Muniz Terrera discussed international collaboration, supporting ECRs and raising standards in research. Hurdles in use of data.

Before our lunch break were our breakout sessions. These sessions allowed delegates to contribute to discussions and share their own perspectives. The first session was on preceptions of healthcare data in research. The second session was focussed on social media. The third session was around the use of data in care homes, with a particular emphasis on COVID.

The afternoon session of the SDRC Conference 2020 was dedicated to our Early Career Researchers. Eight ECRs provided an overview of their research and careers. These presentations highlighted the diversity within the dementia and brain health research community.

Not only was our conference programme full of talented researchers providing oral presentations, we also had a virtual poster display area. In total 15 posters were available to view on the day. We awarded a prize for the best poster- from which there were four winners!

Finally, we are grateful to our exhibitors who hosted virtual stands on the day: Join Dementia Research, Generation Scotland, NHS Research Scotland, Brain Health Scotland

We hope that everyone who attended the Conference enjoyed the day. We also hope you learned something about the dementia and brain health research in Scotland. If you registered for the day, you can login to the event platform using the same details and watch the full SDRC Conference again. We will also be publishing video highlights of the conference shortly if you want to catch up.

You can still keep up with the discussion with the #SDRC2020, follow us on Twitter @sdrc_research

Read more SDRC Latest

The launch of the SDRC Annual Report 2021/22

The SDRC Annual Report 2022, launched at the SDRC Annual Conference on Monday 9th May. It outlines what research has been ongoing in dementia and brain health research in Scotland in the past 12 months. It includes the updates from each of the SDRC Research Themes, as...

Announcement of the Brain Health Alliance for Research Challenge

The SDRC are excited to be part of a new collaborative research alliance, supported by the Scottish Funding Council.  The Scottish Brain Health Alliance for Research Challenge (ARC) is a project that will receive up to £600,000 to create multi-disciplinary,...

SDRC Support for Early Career Researchers

The SDRC aim to be here for all dementia researchers based in Scotland. Of course, supporting ECRs is a key part of this, and we want to do all we can to nurture emerging talent and help develop the future leaders in dementia and brain health research. As was part of...

Dementia Researcher Podcast: Brain Health and Dementia Research Strategy

  On the 18th October, Adam Smith interviewed SDRC Chair Craig Ritchie and Director of Policy and Practice at Alzheimer Scotland on the Dementia Researcher Podcast. They were discussing the recently launched Scottish Brain Health and Dementia Research Strategy....

Call for new members: Scottish Cognitive Ageing Network

The Scottish Cognitive Ageing Network (SCAN) was established in 2022, aimed at formalising and building on cross-institutional links in cognitive ageing research across Scotland. The inaugural meeting took place at the University of Strathclyde in May, with a second...

Research in the News: Football Heading and Dementia Risk

Researchers Glasgow Brain Injury Research Group (GBIRG) led by Associate Professor Willie Stewart, have published their findings reporting a link between a footballers' outfield position and neurodegenerative risk.  Taking place at the University of Glasgow, as part...

Do you have insights to share with other researchers? Write a blog for the SDRC!

We are always looking for SDRC members to feature on our website and write a guest blog for the SDRC. You may already be familiar with our blog series, where we welcome contributions from people with an experience of brain health or dementia research. Blogs are an...

How COVID has Impacted Early Career Researchers: July 2020 Survey Findings

You may be aware, since the start of the pandemic, the SDRC have been communicating with members on the impact of Covid on dementia research. At the start of lockdown, we ran a survey to find out how the pandemic has affected ECRs.  From this we created a report,...

Alzheimer Scotland Centre for Policy and Practice (ASCPP) Annual Celebration Report

The Alzheimer Scotland Centre for Policy and Practice (ASCPP) has launched its Annual Celebration Report to showcase the work of the Centre and celebrate outstanding dementia care during the pandemic.  The ASCPP is led by Professor Debbie Tolson, one of our SDRC...

Aducanumab: Approval of new Alzheimer’s disease drug explained

Aducanumab: Dr Terry Quinn explains approval of new Alzheimer's disease drug  SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the treatment of...